Molecule
Brands
Company
Product Search
by Molecule
by Brands
by Company
NCE
Modified, Unique products
Recent KFDA Approval &
NHI enlisting
API Business info
Customer survey
Based on Production Vol.
DMF-Molecule, Status & Process
(Market & customer)
DMF Filling Status
Patent Status
My API profile Registration
Member's Lounge
General Market Information
KFDA registration process
DMF Filing
National Health Formulary enlisting
Law or Regulation
Major Pharmaceutical company
API importers directory
Distribution & Wholesaler
CRO & Other service Provider
Co-Biz Avenue
PharmaToday
Pharmaceutical Korea
Q & A
FAQ
General Q&A
Market Q&A
Business Inquiry
to Pharmalink
My Page
Company Registration
Company ID Management
Company Profile
Product description
>
API description
My Profile
Contacts in / out
General Q&A
Detail Information
Product Search
Detail Information
Pletaal continus cap.
Company
Korea Otsuka Pharms
ETC/OTC
OTC
MOHSA Class
339
ATC
B01AC
NHI Price
695
Reg/Mark
On sale
Unit
자사
Pill ID
OG OG29 29(Front) (Back)
Composition
cilostazol 100mg
Indication
Dosage
1. 만성동맥폐색증(버거씨병, 폐색성 동맥경화증. 당뇨병성 말초혈관병증 등)에 따른 궤양, 동통 및 냉감 등 허혈성 제증상의 개선
2. 뇌경색(심인성뇌색전증 제외) 발증 후 재발억제
실로스타졸로서 보통 성인 1회 200mg을 1일 1회 경구투여한다.
이 약은 식사를 피하여 공복 상태에서 복용한다. (사용상 주의사항 중 ‘5. 일반적 주의 6)항’ 참조)
Pletaal continus cap.
[Close]
PharmaLink.kr
| Jin BD 2nd floor, Sadangdong 1039-59, Dongjak-Gu, Seoul
E-Mail :
pharmabase@nate.com
Tel : 82-70-7815-2200
Copyright ⓒ2013~2016 PharmaLink.Kr ALL RIGHTS RESERVED.